HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer.

AuthorsKen Suzawa, Michael Offin, Adam J Schoenfeld, Andrew J Plodkowski, Igor Odintsov, Daniel Lu, William W Lockwood, Maria E Arcila, Charles M Rudin, Alexander Drilon, Helena A Yu, Gregory J Riely, Romel Somwar, Marc Ladanyi
JournalJCO precision oncology (JCO Precis Oncol) Vol. 3 ( 2019) ISSN: 2473-4284 [Print] United States
PMID31157314 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: